FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894888448> ?p ?o ?g. }

• W2894888448 abstract "Background Prednisone therapy, Thalidomide, azathioprine, anti–TNF-alpha inhibitors are presently used in resistant mucocutaneous lesions of Behcet’s Disease (BD). In this study, we used only ambulatory Benzathine Penicillin (BP), without being preceded by high doses of penicillin infusion. This Study confirm the value of BP in the treatment of refractory ulcers of BD and point out a probable role of Streptococcus on the pathogenesis of BD Objectives This open Study confirm the value of BP in refractory oral, genital and skin ulcers of BD. We propose to use BP when ulcers of BD are resistant to colchicine 1.5 mg/day and to add BP in the recommendations of EULAR for the treatment of resistant cases of mucocutaneous involvement. Methods 15 patients with BD (12 patients fulfilled all criteria for BD) had Giant (mean size of ulcer superior to 1 cm), or Multiple oral, genital, skin ulcers received BP at the dose of 2.4 million units in intramuscular injection; 3 intramuscular injections with an interval of 3 weeks between injection. Colchicine at the dose of 1 mg/day was maintened. Serology of syphilis was negative. Patients had seen 15 days, 3 months and 1 year after the starting treatment. Results This study started in 2012, in a private office and comprised 15 patients:9 males; 6 females. Arthritis was observed in 11 patients, uveitis in 6 cases. BP was used in 8 patients with oral ulcers(4 Giants and 4 multiples), Genital ulcers in 3 patients (2 multiple and 1 Giant), oral and genital ulcers(2 Multiples) and cutaneous aphtosis in 2 patients 0.2 weeks after the first injection of BP, recovery from ulcers was achieved.BP was administrated a second time with success, in 9 patients who have developed resistant ulcers, after 1 to 3 years of recovery. One patient with panuveitis treated with azathioprine in 2013 and interferon alpha in 2015 and 2017, developed refractory ulcers: Excellent efficacy of BP was observed in this patient. Conclusions In this study, we confirm the recovery from refractory oral, genital and cutaneous ulcers (Giant, Multiple) in these 15 patients with BP. We recommend using more frequently BP and we propose to add BP in the recommendations of EULAR for the treatment of resistant cases of mucocutaneous involvement because treatment with BP is rather easy in outpatients, it is efficient, it has a low cost and have few side-effects References [1] Benamour S, Bettal S, Alaoui Fz and all: Treatment of Giant aphthosis by IV G Penicillin in Behcet’s disease.10 th International Conference on Behcet’s disease. Berlin, June 2002. [2] BENAMOUR S: Benzathine Penicillin in treatment of oral and Genital ulcers in Behcet’s Disease. 17th International Conference on Behcet’s Disease. Matera, 15th-17th September 2016 Disclosure of Interest None declared" @default.
• W2894888448 created "2018-10-12" @default.
• W2894888448 creator A5047222549 @default.
• W2894888448 date "2018-06-01" @default.
• W2894888448 modified "2023-09-23" @default.
• W2894888448 title "AB0699 Benzathine penicillin in treatment of ulcers of behcet’s disease" @default.
• W2894888448 doi "https://doi.org/10.1136/annrheumdis-2018-eular.2245" @default.
• W2894888448 hasPublicationYear "2018" @default.
• W2894888448 type Work @default.
• W2894888448 sameAs 2894888448 @default.
• W2894888448 citedByCount "0" @default.
• W2894888448 crossrefType "proceedings-article" @default.
• W2894888448 hasAuthorship W2894888448A5047222549 @default.
• W2894888448 hasBestOaLocation W28948884481 @default.
• W2894888448 hasConcept C126322002 @default.
• W2894888448 hasConcept C141071460 @default.
• W2894888448 hasConcept C16005928 @default.
• W2894888448 hasConcept C2779134260 @default.
• W2894888448 hasConcept C2781428731 @default.
• W2894888448 hasConcept C71924100 @default.
• W2894888448 hasConcept C90924648 @default.
• W2894888448 hasConceptScore W2894888448C126322002 @default.
• W2894888448 hasConceptScore W2894888448C141071460 @default.
• W2894888448 hasConceptScore W2894888448C16005928 @default.
• W2894888448 hasConceptScore W2894888448C2779134260 @default.
• W2894888448 hasConceptScore W2894888448C2781428731 @default.
• W2894888448 hasConceptScore W2894888448C71924100 @default.
• W2894888448 hasConceptScore W2894888448C90924648 @default.
• W2894888448 hasLocation W28948884481 @default.
• W2894888448 hasOpenAccess W2894888448 @default.
• W2894888448 hasPrimaryLocation W28948884481 @default.
• W2894888448 hasRelatedWork W1899190561 @default.
• W2894888448 hasRelatedWork W1965694031 @default.
• W2894888448 hasRelatedWork W1985728577 @default.
• W2894888448 hasRelatedWork W1996825874 @default.
• W2894888448 hasRelatedWork W2076064330 @default.
• W2894888448 hasRelatedWork W2113682734 @default.
• W2894888448 hasRelatedWork W2120390079 @default.
• W2894888448 hasRelatedWork W2152352348 @default.
• W2894888448 hasRelatedWork W2159833923 @default.
• W2894888448 hasRelatedWork W2368130239 @default.
• W2894888448 hasRelatedWork W2463388016 @default.
• W2894888448 hasRelatedWork W2542350607 @default.
• W2894888448 hasRelatedWork W2554307475 @default.
• W2894888448 hasRelatedWork W2807867470 @default.
• W2894888448 hasRelatedWork W2945541762 @default.
• W2894888448 hasRelatedWork W2950811944 @default.
• W2894888448 hasRelatedWork W2954263115 @default.
• W2894888448 hasRelatedWork W3034615981 @default.
• W2894888448 hasRelatedWork W3143884519 @default.
• W2894888448 hasRelatedWork W90416353 @default.
• W2894888448 isParatext "false" @default.
• W2894888448 isRetracted "false" @default.
• W2894888448 magId "2894888448" @default.
• W2894888448 workType "article" @default.